H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares trading hands.
H. Lundbeck A/S Trading Down 0.0 %
The firm has a market cap of $21.91 billion, a P/E ratio of 25.00 and a beta of 0.68. The stock has a 50 day simple moving average of $22.00 and a 200-day simple moving average of $22.00. The company has a current ratio of 1.15, a quick ratio of 0.71 and a debt-to-equity ratio of 0.32.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
See Also
- Five stocks we like better than H. Lundbeck A/S
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
- Transportation Stocks Investing
- Toyota vs Tesla: The Tortoise And The Hare Race Has A New Meaning
- How to Invest in Fertilizer
- 5 Critical Takeaways From MongoDB’s Q2 Results for AI Investors
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
